Breast cancer occurred after treatment for Hodgkin's disease: Analysis of 133 cases

Radiotherapy and Oncology

Volumn 59, Issue 3, 2001, Pages 247-255

  Cutuli, Bruno ^a   Borel, Christian ^a   Dhermain, Frédéric ^b   Magrini, Stefano M ^c   Wasserman, Todd H ^d   Bogart, Jeffrey A ^e   Provencio, Mariano ^f   De Lafontan, Brigitte ^g   De La Rochefordiere, Anne ^h   Cellai, Enrico ⁱ   Graic, Yvon ^j   Kerbrat, Pierre ^k   Alzieu, Claude ^l   Teissier, Eric ^m   Dilhuydy, Jean Marie ⁿ   Mignotte, Hervé ^o   Velten, Michel ^a  

^a CENTRE PAUL STRAUSS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Istituto del Radio   (Italy)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^g INSTITUT CLAUDIUS REGAUD   (France)

^h INSTITUT CURIE   (France)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j CENTRE HENRI BECQUEREL   (France)

^k CENTRE EUGÈNE MARQUIS   (France)

^l INSTITUT PAOLI CALMETTES   (France)

^m CENTRE ANTOINE LACASSAGNE   (France)

ⁿ INSTITUT BERGONIÉ   (France)

^o CENTRE LÉON BÉRARD   (France)

more..

Author keywords

Breast cancer; Conservative treatment; Ductal carcinoma in situ; Hodgkin's disease; Radio induced cancers; Secondary cancers

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; PREDNISONE; TAMOXIFEN;

BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOMA IN SITU; DISEASE ASSOCIATION; DISEASE COURSE; HODGKIN DISEASE; HUMAN; INVASIVE CARCINOMA; MASTECTOMY; METASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADIATION CARCINOGENESIS; RADIOSURGERY; RECURRENT DISEASE; REMISSION; REVIEW; RISK FACTOR; SCREENING TEST; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHILD; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0035370970     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00337-1     Document Type: Review

References (62)

1. Abrahamsen J.F., Andersen A., Hannislal E., et al. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age. J Clin Oncol. 11:1993;255-261.
2. Aisenberg A.C., Finkelstein D.M., Doppke K.P., Boivin J.F., Willet C.G. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 79:1997;1203-1210.
3. Anderson N., Lokich J. Bilateral breast cancer after cured Hodgkin's disease. Cancer. 65:1990;221-223.
4. Bathia S., Robison L.L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 334:1996;745-751.
5. Beaty O. III, Hudson M.M., Greenwald C., et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol. 13:1995;603-609.
6. Biti G., Cellai E., Magrini S.M., Papi M.G., Ponticelli P., Boddi V. Second solid tumours and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution. Int J Radiat Oncol Biol Phys. 29:1994;25-31.
7. Boice J.D. Second cancer after Hodgkin's disease: the price of success? J Natl Cancer Inst. 85:1993;4-5.
8. Boivin J.F., Hutchison G.B., Zauber A.G., et al. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst. 87:1995;732-741.
9. Boivin J.F. Second cancer and other late side effects of cancer treatment. A review. Cancer. 65:1990;770-775.
10. Carey R.W., Linggood R.M., Wood W., Blitzer P.H. Breast cancer developing in four women cured of Hodgkin's disease. Cancer. 54:1984;2234-2236.
11. Christie D.R., Wills R., Drew J., Barton M. The doses received by the breast during mantle radiotherapy. Int J Radiat Oncol Biol Phys. 41:1998;223-226.
12. Chung T.C., Bogart J.A., Adams J.F., et al. Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 37:1997;405-409.
13. Cimino G., Papa G., Tura S., et al. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study. J Clin Oncol. 9:1991;432-437.
14. Colvett K.T. Bilateral breast carcinoma after radiation therapy for Hodgkin's disease. South Med J. 88:1995;239-242.
15. Cook K.L., Adler D.D., Lichter A.S., Ikeda D.M., Helvie M.A. Breast carcinoma in young women previously treated for Hodgkin's disease. Am J Roentgenol. 155:1990;39-42.
16. Cosset J.M., Henry-Amar M., Dietrich P.Y., et al. Les tumeurs solides secondaires après irradiation pour maladie de Hodgkin: l'expérience de l'Institut Gustave Roussy. Bull Cancer. 79:1992;387-388.
17. Cosset J.M., Henry-Amar M. Maladie de Hodgkin: les complications à long terme de la radiothérapie. Presse Médicale. 26:1997;1107-1112.
18. Cutuli B. Radiation induced breast cancer after treatment for Hodgkin's disease. J Clin Oncol. 16:1998;2285-2286.
19. Cutuli B., Dhermain F., Borel C., et al. Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients. Eur J Cancer. 33:1997;2315-2320.
20. De la Rochefordiere A., Asselain B., Campana F., et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet. 341:1993;1039-1043.
21. De la Rochefordiere A., Asselain B., Scholl S., et al. Simultaneous breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys. 30:1994;35-41.
22. Dershaw D.D., Yahalom J., Petrek J.A. Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation. Radiology. 184:1992;421-423.
23. Donaldson S.S. Hodgkin's disease in children. Semin Oncol. 17:1990;736-748.
24. Gervais-Fagnou D.G., Girouard C., Lapierre N., Pintillie M., Goss P.E. Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease. Oncology. 57:1999;224-231.
25. Glanzmann C., Veraguth A., Lutolf U.M. Incidence of second solid cancer after treatment of Hodgkin's disease. Strahlenther Onkol. 170:1994;140-146.
26. Goss P.E., Sierra S. Current perspective on radiation-induced breast cancer. J Clin Oncol. 16:1998;338-347.
27. Hancock S.L., Hoppe R.T. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol. 6:1996;225-242.
28. Hancock S.L., Tucker M.A., Hoppe R.T. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst. 85:1993;25-31.
29. Harding C., Bundred N.J. Unilateral breast cancer after previous mantle radiotherapy: is bilateral mastectomy justified? Breast. 5:1996;267-269.
30. Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease. Ann Oncol. 3:(Suppl 4):1992;S117-S128.
31. Janjan N.A., Wilson J.F., Gillin M., et al. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer. 61:1988;252-254.
32. Kaldor J.M., Lasset C. Second malignancies following Hodgkin's disease. Somers R., Henry-Amar M., Meerwaldt J.K., Carde P. Treatment strategy in Hodgkin's disease. 1990;139-150 John Libbey-Eurotext, Montrouge.
33. Kaste S.C., Hudson M.M., Jones D.J., et al. Breast masses in women treated for childhood cancer. Incidence and screening guidelines. Cancer. 82:1998;784-792.
34. Kowalski A., Smith S. Measurement of radiation dose delivered to breast tissue during month field irradiation for Hodgkin's disease. Med Dosim. 23:1998;31-36.
35. Land C.E., Boice J.D. Jr., Shore R.E., Norman J.E., Tokunaga M. Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. J Natl Cancer Inst. 65:1980;353-376.
36. Land C.E. Low-dose radiation. A cause of breast cancer? Cancer. 46:1980;868-873.
37. Levitt S.H., Lee C.K.K., Aeppli D., Lindgren B., Peterson B.A. The role of radiation therapy in Hodgkin's disease: experience and controversy. Cancer. 70:1992;693-703.
38. Levitt S.H., Mandel J.S. Breast carcinogenesis: risk of radiation. Int J Radiat Oncol Biol Phys. 11:1985;1421-1423.
39. Mauch P.M., Kalish L.A., Marcus K.L., et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood. 87:1996;3625-3632.
40. Metayer C., Lynch C.F., Clarke E.A., et al. Second cancer among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol. 18:2000;2435-2443.
41. Miller R.W., Van de Geijn J., Raubitschek A.A., Orr K., Odunieff P., Glatstein E. Dosimetric considerations in treating mediastinal disease with mantle fields: characterisation of the dose under mantle blocks. Int J Radiat Oncol Biol Phys. 32:1995;1083-1095.
42. Munker R., Grützner S., Hiller E., et al. Second malignancies after Hodgkin's disease: the Munich experience. Ann Hematol. 78:1999;544-554.
43. O'Brien P.C., Barton M.C., Fisher R. Breast cancer following treatment for Hodgkin's disease: the need for screening in a young population. Australas Radiol. 39:1995;271-276.
44. Peters M.H., Sonpal I.M., Batra M.K. Breast cancer in women following mantle irradiation for Hodgkin's disease. Am Surg. 61:1995;763-766.
45. Rodriguez M.A., Fuller L.M., Zimmermann S.O., et al. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann Oncol. 4:1993;125-131.
46. Roubidoux M.A., Helvie M.A., Lai N.E., Paramagul C. Bilateral breast cancer: early detection with mammography. Radiology. 196:1995;427-431.
47. Rubin P., Zagars G., Chuang C., Thomas E.M. Hodgkin's disease: is there a price for successful treatment? A 25-year experience. Int J Radiat Oncol Biol Phys. 12:1986;153-166.
48. Sankila R., Garwicz S., Olser J.H., et al. Risk of subsequent malignant neoplasm among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five northern countries. J Clin Oncol. 14:1996;1442-1446.
49. Shapiro C.L., Mauch P.M. Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective. J Clin Oncol. 10:1992;1662-1665.
50. Swerdlow A.J., Douglas A.J., Hudson Vaughan G., Hudson Vaughan B., Bennett M.H., Mac Lennan K.A. Risk of second primary cancer after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British national lymphoma investigation. Br Med J. 304:1992;1137-1143.
51. Swerdlow A.J., Barber J.A., Vaughan Hudson G., et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 18:2000;498-509.
52. Tardivon A.A., Garnier M.L., Beaudré A., Girinsky T. Breast carcinoma in women previously treated for Hodgkin's disease. Clinical and mammographic findings. Eur Radiol. 9:1999;1666-1671.
53. Tinger A., Wasserman T.H., Klein E.E., et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys. 37:1997;865-870.
54. Tucker M., Coleman C., Cox R., Varghese A., Rosenberg S.A. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 318:1988;76-81.
55. Valagussa P. Second neoplasm following treatment of Hodgkin's disease. Curr Opin Oncol. 5:1993;805-811.
56. Van Leeuwen F.E., Klokman W.J., Hageenbeek A., et al. Second cancer risk following Hodgkin's disease: a 20 years follow-up study. J Clin Oncol. 12:1994;312-325.
57. Van Leeuwen F.E., Swerdlow A.J., Valagussa P., Tucker M.A. Second cancer after treatment of Hodgkin's disease. Mauch P.M., Armitage J.O., Diehl V., Hoppe R.T., Weiss L.M. Hodgkin's disease. 1999;607-632 Lippincott, Williams and Wilkins, Philadelphia, PA.
58. Van Leeuwen F.E., Klokman W.J., Van't Veer M.B., et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 18:2000;487-497.
59. Wolden S.L., Lamborn K.R., Cleary S.F., et al. Second cancer following paediatric Hodgkin's disease. J Clin Oncol. 16:1998;536-544.
60. Wolden S.L., Hancock S.L., Carlson R.W., Goffinet D.R., Jeffrey S.S., Hoppe R.T. Management of breast cancer after Hodgkin's disease. J Clin Oncol. 18:2000;765-772.
61. Yahalom J., Petrek J.A., Biddinger P.W., et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol. 10:1992;1674-1681.
62. Zellmer D.L., Wilson J.F., Janjan N.A. Dosimetry of the breast for determining carcinogenic risk in mantle irradiation. Int J Radiat Oncol Biol Phys. 21:1991;1343-1351.